Tag: bucindolol

Biotech Company Applies for FDA Permission to Market Gene-Targeted Heart Failure Drug

Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to treat. The beta-blocker drug bucindolol met that fate in 2001 when it was originally tested as a treatment for heart ...

Read more

Return to top

Warning: file_get_contents(http://urls.api.twitter.com/1/urls/count.json?url=http%3A%2F%2Fblog.23andme.com%2Fhealth-traits%2Fgood-news-for-coffee-drinkers%2F) [function.file-get-contents]: failed to open stream: HTTP request failed! HTTP/1.1 410 Gone in /home/ttandme/dreamblog.23andme.com/wp-content/plugins/most-shared-posts/msp-fetch.php on line 179

Fatal error: Allowed memory size of 94371840 bytes exhausted (tried to allocate 71 bytes) in /home/ttandme/dreamblog.23andme.com/wp-includes/meta.php on line 838